These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30408586)

  • 1. Validation and meta-analysis of kappa index biomarker in multiple sclerosis diagnosis.
    Menéndez-Valladares P; García-Sánchez MI; Adorna Martínez M; García De Veas Silva JL; Bermudo Guitarte C; Izquierdo Ayuso G
    Autoimmun Rev; 2019 Jan; 18(1):43-49. PubMed ID: 30408586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
    Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis.
    Menéndez-Valladares P; García-Sánchez MI; Cuadri Benítez P; Lucas M; Adorna Martínez M; Carranco Galán V; García De Veas Silva JL; Bermudo Guitarte C; Izquierdo Ayuso G
    Mult Scler J Exp Transl Clin; 2015; 1():2055217315620935. PubMed ID: 28607709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
    PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
    Monreal E; Fernández-Velasco JI; García-Soidán A; Sainz de la Maza S; Espiño M; Villarrubia N; Rodríguez-Jorge F; Chico-García JL; Sainz-Amo R; Masjuan J; Costa-Frossard L; Villar LM
    Front Immunol; 2023; 14():1288169. PubMed ID: 37954589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.
    Thevarkalam M; Krishnan S; Shanmughan LI; Mathai A; Leelamani JV; Kannoth S; Bhaskaran R; Iype T; Panda S
    Mult Scler Relat Disord; 2023 Jun; 74():104717. PubMed ID: 37062197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: The key role of kappa free light chains and a multivariate predictor for disease progression.
    Miklušová M; Fürst T; Zimek D; Mareš J
    Mult Scler Relat Disord; 2024 Feb; 82():105402. PubMed ID: 38160638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.
    Villar LM; García-Barragán N; Sádaba MC; Espiño M; Gómez-Rial J; Martínez-San Millán J; González-Porqué P; Alvarez-Cermeño JC
    J Neurol Sci; 2008 Mar; 266(1-2):34-7. PubMed ID: 17884100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
    Leurs CE; Twaalfhoven H; Lissenberg-Witte BI; van Pesch V; Dujmovic I; Drulovic J; Castellazzi M; Bellini T; Pugliatti M; Kuhle J; Villar LM; Alvarez-Cermeño JC; Alvarez-Lafuente R; Hegen H; Deisenhammer F; Walchhofer LM; Thouvenot E; Comabella M; Montalban X; Vécsei L; Rajda C; Galimberti D; Scarpini E; Altintas A; Rejdak K; Frederiksen JL; Pihl-Jensen G; Jensen P; Khalil M; Voortman MM; Fazekas F; Saiz A; La Puma D; Vercammen M; Vanopdenbosch L; Uitdehaag B; Killestein J; Bridel C; Teunissen C
    Mult Scler; 2020 Jul; 26(8):912-923. PubMed ID: 31066634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal kappa free light chains as markers for multiple sclerosis.
    Vecchio D; Bellomo G; Serino R; Virgilio E; Lamonaca M; Dianzani U; Cantello R; Comi C; Crespi I
    Sci Rep; 2020 Nov; 10(1):20329. PubMed ID: 33230241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.